The Hinz Protocol™
Approach To Parkinson's
What if there was a way to eliminate symptoms and slow or stop progression of Parkinson’s disease?

This is the most effective care available for Parkinson's Disease.

Our Perspective

89% of Parkinson’s disease patients take L-dopa (a dopamine precursor) with other medications.

The Hinz Protocol™ dopamine precursor approach does not use these traditional prescriptions associated to Parkinson's disease care, which may cause:

  • The 376% increase the Parkinson’s disease death rate.
  • Known to cause and exacerbate nutritional deficiencies.
  • Can induce nutritional deficiencies with symptoms identical to Parkinson’s disease symptoms.
  • Can facilitate progression of brain damage causing Parkinson’s disease.
  • Can cause the dopamine precursor to quit working.
  • They are the primary cause of dyskinesias, and choreiform movement disorder thought to be due to dopamine precursors in the past.

The Hinz Protocol™ Approach

Permanent and irreversible brain damage is the cause of Parkinson’s disease. There is no cure. None. After the diagnosis of Parkinson’s disease occurs, it only gets worse.

A relative nutritional deficiency occurs when an optimal diet does not meet the needs of the system. In developing the Hinz Protocol™ we found the only way to slow or halt the progression while achieving optimal Parkinson’s symptoms control of Parkinson’s, is managing all associated nutritional deficiencies. Inadequate systemic dopamine represents a relative nutritional deficiency of the nutrients the body uses to make dopamine. Normal people make enough dopamine from dietary nutrients. To restore normal function Parkinson’s disease patients require supplementation with dopamine precursors and other nutrients.

The following is from the peer-reviewed scientific papers our doctors published:

  • “A nutrient is any substance that facilitates normal system function. A drug is any substance that induces abnormal system function. A nutrient may become a drug. A drug may not become a nutrient. When a dopamine precursor is administered as a single agent, it may deplete serotonin, and would then be considered a drug, not a nutrient.” Neuropsychiatric Disease and Treatment 2016:12 763–775

When a dopamine precursor displays side effects it is no longer acting as a nutrient; it has become a drug. Dopamine precursors are associated side effects are from imbalances between dopamine and other systems. The standard response of medicine to these nutritional deficiency driven symptom is to give the traditional prescriptions associated with Parkinson's disease care, which cause further nutritional deficiencies. A drug cannot effectively address a nutritional deficiency; only nutrients can. Improper management of the patient’s nutritional deficiencies leaves the patient with Parkinson’s disease symptoms, side effects, and deterioration. So, what does the Hinz Protocol™ do? Our approach is to put the patient in a state of normal feeling and normal function once again. First, we keep nutrients functioning as nutrients. Whenever nutrients in the form of dopamine precursors display side effects, they are functioning as a drug. Second, we optimally address the 29 relative nutritional deficiencies associated with Parkinson’s disease and its treatment. Only when we optimally address nutritional deficiencies can patients achieve optimal relief of symptoms with no side effects.

For more information on your approach to Parkinson’s disease send an email to This email address is being protected from spambots. You need JavaScript enabled to view it. or call +01-218-626-2220 (877-626-2220). After you send your email, we may ask for more information. All communications will be kept confidential. If you have any questions, please call us free of charge.

How Effective Is Our Hinz Protocol™ Telemedicine Approach?


Simply talking to the patient on the phone or voice only on the internet does not qualify as telemedicine. There must be an internet hookup where both voice and video (cameras) exists on both ends of the interaction.

This approach provides worldwide telemedicine care. This care represents state of the art regarding 21 years of medical research that started in 1997. This research project, with the University of Minnesota Medical School in Duluth, Minnesota USA has published 22 peer-reviewed research papers in the medical journals documenting its findings.

There is no disagreement among doctors who care for Parkinson’s disease that the most effective treatment for Parkinson’s disease is L-dopa. While there are other drugs used to treat Parkinson’s disease their power and potential runs a distant second to L-dopa. Traditional L-dopa prescribing has a huge downside, increasing side effects and decreasing effectiveness.

Parkinson’s disease patient’s symptoms, in most cases, do not experience lack of progression (deterioration) under this approach. How does this affect patient care? Answer:

1.) In the years to come, the patient is taking the same daily dose of pills.
2.) Relief of symptoms achieved at the time of optimization does not deteriorate.

Typically, it may take 4 to 6 months of weekly visits to achieve optimal results.
The American Medical Association (AMA) has gone on record stating that telemedicine Parkinson’s disease care may be just as effective as face-to-face care in the clinic, see the attached paper.

Telemedicine
Would you like more information on our unique approach to Parkinson's disease care?